According to new research from Wake Forest University School of Medicine and colleagues. Up until age 80, older adults not only gain fat as they age – but because of the obesity epidemic – they actually begin their older years fatter.
Read More »Periodontitis Effects Nephropathy and End-Stage Renal Disease in Type 2 Diabetes
Periodontitis predicts development of overt nephropathy and ESRD in individuals with type 2 diabetes.
Read More »Cannabinoid Spray (Sativex) Improves Neuropathic Pain
GW Pharmaceuticals announced preliminary results of two Phase III studies of Sativex®, its cannabinoid spray medicine, in peripheral neuropathic pain.
Read More »C-Peptide Replacement Improves Early Diabetic Neuropathy
C-peptide improves sensory nerve function in type 1 diabetic patients with early-stage diabetic neuropathy.
Read More »Gene Associated with Kidney Failure in Diabetes Identified
Discovery can lead to treatment strategies for diabetic patients to protect them from kidney failure and may provide a marker to determine which diabetic patients are at increased risk for future kidney disease.
Read More »Kidney Disease Linked to Increased Risk of Peripheral Artery Disease
Chronic kidney disease is a risk factor for peripheral artery disease (PAD)—a common but often undetected condition causing reduced blood flow in the legs.
Read More »Cymbalta Treatment of Neuropathic Pain May Affect Glycemic Control
Duloxetine was linked with modest changes in glycemia in patients with diabetic peripheral neuropathic pain (DPNP), according to the results of 3 randomized trials.
Read More »Cracking the Code of Longevity and Decreasing Dementia
For those lucky few who make it to the century mark, a crucial gene variation relating to HDL cholesterol levels may play an important part in their longevity.
Read More »Risk of Complications in Youth-Onset Type 2 Diabetes
More aggressive screening and treatment is needed in children with type 2 diabetes to prevent complications as they get older.
Read More »Drug Treatment Slows Macular Vision Loss in Diabetics
A drug commonly used to slow the loss of central vision has shown promise in stemming a common precursor of blindness in diabetics, which involves the same central light-sensitive area of retina, scientists report.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.